Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas

被引:68
作者
Karihtala, Peeter [1 ,2 ]
Kauppila, Saila [2 ,3 ]
Soini, Ylermi [4 ,5 ]
Arja-Jukkola-Vuorinen [1 ,2 ]
机构
[1] Oulu Univ Hosp, Dept Radiotherapy & Oncol, Oulu, Finland
[2] Univ Oulu, Oulu, Finland
[3] Oulu Univ Hosp, Dept Pathol, Oulu, Finland
[4] Oulu Univ Hosp, Dept Pathol, Kuopio, Finland
[5] Univ Eastern Finland, Dept Clin Pathol & Forens Med, Inst Clin Med, Sch Med,Canc Ctr Eastern Finland, Kuopio, Finland
关键词
CANCER; PEROXIREDOXINS; CARCINOGENESIS; 8-HYDROXYDEOXYGUANOSINE; SURVIVAL; NRF2;
D O I
10.1186/1471-2407-11-262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) are breast cancer subtypes with an especially poor prognosis. 8-Hydroxydeoxyguanosine (8-OHdG) is a widely used marker of oxidative stress and the redox-state-regulating enzymes peroxiredoxins (PRDXs) are efficient at depressing excessive reactive oxygen species. NF-E2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) are redox-sensitive transcription factors that regulate PRDX expression. This is the first study to assess oxidative stress and or cell redox state-regulating enzymes in TNBC and BLBC. Methods: We assessed immunohistochemical expression of 8-OHdG, Nrf2, Keap1, PRDX III and PRDX IV in 79 women with invasive ductal breast carcinomas. Of these tumors, 37 represented TNBC (grade II-III tumors with total lack of ER, PR and human epidermal growth factor receptor 2 [HER2] expression). Control cases (n = 42) were ER-positive, PR-positive and HER2-negative. Of the 37 TNBCs, 31 had BLBC phenotype (TNBC with expression of cytokeratin 5/6 or epidermal growth factor receptor 1). Results: Patients with TNBC had worse breast cancer-specific survival (BCSS) than the control group (p = 0.015). Expression of 8-OHdG was significantly lower in TNBC than in the non-TNBC group (p < 0.005). 8-OHdG immunostaining was associated with better BCSS (p = 0.01), small tumor size (p < 0.0001) and low grade (p < 0.0005). Keap1 overexpression was observed in the TNBC cohort (p = 0.001) and Keap1-positive patients had worse BCSS than Keap1-negative women (p = 0.014). PRDX IV was overexpressed in the TNBC vs. the non-TNBC group (p = 0.022). Conclusions: Cellular redox state markers may be promising targets when elucidating the pathogenesis of TNBC.
引用
收藏
页数:6
相关论文
共 28 条
[1]   Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype [J].
Cheang, Maggie C. U. ;
Voduc, David ;
Bajdik, Chris ;
Leung, Samuel ;
McKinney, Steven ;
Chia, Stephen K. ;
Perou, Charles M. ;
Nielsen, Torsten O. .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1368-1376
[2]   ESTRADIOL AND PROGESTERONE-RECEPTOR LEVELS IN HUMAN-BREAST CANCER IN RELATION TO CYTOSOL AND PLASMA ESTROGEN LEVEL [J].
DRAFTA, D ;
PRISCU, A ;
NEACSU, E ;
GANGURA, M ;
SCHINDLER, AE ;
STROE, E ;
ANGHEL, C ;
PANAITESCU, G .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 18 (04) :459-463
[3]   Expression of luminal and basal cytokeratins in human breast carcinoma [J].
El-Rehim, DMA ;
Pinder, SE ;
Paish, CE ;
Bell, J ;
Blamey, R ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :661-671
[4]  
Ellis, 2003, INT AGENCY RES CANC, V5, P13
[5]   The phenotypic spectrum of basal-like breast cancers: a critical appraisal [J].
Fadare, Oluwole ;
Tavassoli, Fattaneh A. .
ADVANCES IN ANATOMIC PATHOLOGY, 2007, 14 (05) :358-373
[6]   Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers [J].
Felty, Q ;
Xiong, WC ;
Sun, DM ;
Sarkar, S ;
Singh, KP ;
Parkash, J ;
Roy, D .
BIOCHEMISTRY, 2005, 44 (18) :6900-6909
[7]   Triple-Negative Breast Cancer [J].
Foulkes, William D. ;
Smith, Ian E. ;
Reis-Filho, Jorge S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1938-1948
[8]   Triple-negative breast cancer-current status and future directions [J].
Gluz, O. ;
Liedtke, C. ;
Gottschalk, N. ;
Pusztai, L. ;
Nitz, U. ;
Harbeck, N. .
ANNALS OF ONCOLOGY, 2009, 20 (12) :1913-1927
[9]  
Ishii Tetsuro, 2007, V44, P375
[10]   Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization [J].
Isola, J ;
Tanner, M ;
Forsyth, A ;
Cooke, TG ;
Watters, AD ;
Bartlett, JMS .
CLINICAL CANCER RESEARCH, 2004, 10 (14) :4793-4798